FGF21 exerts considerable pharmacological effects in ameliorating hyperglycaemia, dyslipidaemia and obesity as has been consistently replicated in rodent5, 6, 8 and monkey30 models of diabetes mellitus. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.